Adverse events self-reported by patients with extensive-stage small-cell lung cancer in the phase III CASPIAN study.
Adverse events self-reported by patients with extensive-stage small-cell lung cancer in the phase III CASPIAN study. Future Oncol. 2025 May; 21(12):1511-1523.